In vivo acute toxicity studies of novel anti-melanoma compounds downregulators of hnrnph1/h2

HIGHLIGHTS

• who: Sadeeshkumar Velayutham and collaborators from the Rumbaugh-Goodwin Institute for Cancer Research, Nova Southeastern University, College CCR r605, Fort Lauderdale, FL, USA have published the research: In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2, in the Journal: Biomolecules 2023, x of 10/02/2023
• what: Given the lack of knowledge about the side effects of using spliceosomal binders in humans an acute toxicity study was conducted to evaluate these in mice. The results of this study demonstrate the lack of acute toxicity after sc administration of two novel . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.